Trial NCT02336048

View at ClinicalTrials.gov 
Org. Study IDs: BO29448
Secondary IDs: 2014-004594-16

Last trial update was posted on 2021-04-08

MeSH Interventions

Chlorambucil Obinutuzumab

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid

Other Conditions

B-Cell Chronic Lymphocytic Leukemia

Stopping Reasons

This study was terminated early because premedication with tocilizumab was unlikely to reduce the risk of IRR.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID